NR 508 - ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS (VERSION 3).
NR 508 - ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS (VERSION 3)/NR 508 - ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS (VERSION 3). A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should:
Escuela, estudio y materia
- Institución
- Kaplan University
- Grado
- NR 508 (NR508)
Información del documento
- Subido en
- 5 de enero de 2021
- Número de páginas
- 27
- Escrito en
- 2020/2021
- Tipo
- Examen
- Contiene
- Preguntas y respuestas
Temas
-
nr 508 advanced pharm possible midterm questions and answers version 3